StockWatch
·

NRB BEARINGS LTD. Q2 FY27 Results

NRBBEARINGQ2 FY27 Results
Filing
Result:Good· Market: Crashed#Margin expansion#One-off hit

Outlook: Cautiously Optimistic · Guidance: Maintained

MetricValue (₹ Cr)Q1 FY27Q2 FY26
Revenue386.364.5%18.8%
Total Income390.494.1%15.0%
Expenditure341.814.8%19.0%
PBT48.685.3%7.1%
Net Profit36.244.0%12.5%
OPM17.32%0.62pp0.85pp
NPM9.28%0.79pp2.92pp
EPS3.663.7%12.7%
View full financials

Core industrials metrics are strong (revenue +18.8% YoY, OPM up to 17.3% from 16.5%, ex-other-income PBT +17%), but headline PAT fell 12.5% chiefly due to other income dropping from ₹14.3cr to ₹4.1cr plus a higher tax rate, not core weakness.

NRB BEARINGS LTD. · QQ2 FY-2027 · THE CALL

Strong growth masks profit decline; strategy credible, execution uncertain

The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.

12 Nov 2026 · 6 min read
Verdict

Hold

confidence 6/10

Credibility

Grade B

Delivered 18.8% revenue growth vs stated 15% aspirational (beat), but profit fell sharply vs prior-year baseline. EBITDA margin 18.2% met guidance (18–20%), but PAT conversion weakened. Management refusal to guide quarterly metrics obscures near-term traction.

Short-term outlook

Cautiously Optimistic

next 1–2 quarters

Long-term outlook

Optimistic

multi-year

Management credibly articulates a 5-year engineering/EV/aerospace pivot, with capex and JV mechanisms in place. However, the delivered quarter reveals margin compression: revenue grew 18.8% but PAT fell 12.5%, and OPM declined QoQ despite 4.6% sequential revenue gain. The core risk is whether organic profit growth can materialize while funding JVs and product development.

₹386.4 Cr

Revenue · +18.8% YoY

₹36.2 Cr

Reported PAT · −12.5% YoY

Compressing

Margins · vs guidance: Mixed

Did the claims hold up?

Management's claims vs. the numbers

Revenue ₹386 Cr, 18.8% YoY growth

Delivered ₹386.4 Cr at 18.8% YoY — exact match

MET

EBITDA ₹71 Cr at 18.2% margin

71/386.4 = 18.4%, within guided 18–20% range

MET

Broad-based growth; CV segment up 47%, Industrial up 48%

Segment growth stated but not audited; overall 18.8% YoY consistent with mix

MET

Quality of growth improved; deeper customer engagement, high-value product mix

PAT fell 12.5% YoY, NPM compressed from ~10.6% YoY to 9.3%, QoQ PAT -4% despite 4.6% revenue growth

MISS

COGS control: costs rose only ~1% despite organic growth

OPM 17.3% delivered; peer COGS typically rise with mix/scale. Unverified but plausible given cost discipline narrative

Partially Supported

Earnings quality

What changed since the last call

Deltas vs. the prior call

Growth trajectory implied raised to 20%

Upgrade

Management said 'moving into growth trajectory towards 20%' (vs prior 14.38% CAGR extrapolation). Informal; no new quantified FY27/28 target given. Prior ₹2,730 Cr FY31 maintained.

Margin expansion timing pushed out

Neutral

Reaffirmed 18–20% EBITDA goal, but Q2 at lower end (18.2%); management said 'once we reach new threshold' implying scale-dependent. No cut, but cautiousness vs. prior optimism.

Capex phased across ₹270 Cr total unchanged

Neutral

Unitec JV (₹110 Cr) on track April 2027. No new capex commitments; investment thesis unchanged.

The Q&A

Analysts pressed hard on quarterly guidance gap (15% prior aspiration vs 19% delivered), segment specificity (non-auto definition), and profit decline. Management deflected with 'conservative' messaging and 'long-term' framing, refusing near-term numeric commitments. Tone was assertive on moat (aerospace, EV readiness) but evasive on cost/mix sensitivity. Management held ground, didn't concede misses.

The exchanges that mattered

Growth guidance delta — Siddhart Mantri, InvestQ

Dodged

No, we are a conservative company; we like to over-perform. We are now moving to a 20% growth trajectory. For H2, we will sustain this if capacity and new customer wins materialize.

EBITDA leverage — Siddhart Mantri, InvestQ

Partial

We maintain 17–18% EBITDA ratio. Once we reach a new threshold of growth, we intend to sustain and surpass it. We are not quarterly-driven; annual view.

Unitec JV ramp — Varun Jain, Dolat Capital

Answered

On track for April 2027. ₹130 Cr is revenue potential, not FY28 target. Full utilization will take time; we don't assume full capacity in year one.

Industrial segment JV — Aditya Miglani, Burman Capital

Answered

Broad industrial applications—heavy friction, sealing, lubrication. One customer recently listed on stock exchange. High growth potential in India. We are the best-fit partner for this.

Leadership pipeline — Lakshminarayanan KG, Tunga Investments

Over-Answered

We acquire 20–40 management trainees annually from top engineering colleges. Our approach is mentorship-driven, not hire-from-market. We promote within rapidly. We give 20–30% salary jumps and leadership roles to high performers.

Other expenses cost inflation — Nisarg Shah, Pkeday Investments

Partial

COGS control has been excellent (barely 1% rise). New product development and pricing takes real-world costs into account. Power, fuel, logistics have inflated. We will offset with higher growth trajectory and capacity ramps.

Segment wins — Shreyas Gathani, SG Securities

Partial

We don't disclose quarterly wins; we do it half-yearly. Top 10 customers represent bulk of sales. Internationally, we're seeing BMW content uplift. CV faced some headwinds but still posted 40%+ growth.

Non-auto segment definition — Abhishek Jain, KRIIS PMS

Dodged

Every company defines 'auto' differently. Ours is the widest—includes 2/3-wheelers, passenger cars, CVs, farm equipment, LCV, HCV, industrial. Industrial is 48% growth (vs 34% prior promise). Our definition reflects complexity; we're a versatile company.

Mahant Tool Room scale — Shreya Bajaj, Serene Alpha

Answered

Q2 revenue ₹55 lakh (early stage). Started at ₹2.5 Cr turnover, moving to ₹1 Cr quarterly over 9 months. Growth comes in years 4–5. It's a long-cycle business with certification lead times (18 months minimum for MTR product range).

Aerospace supply shortage — Abhishek Sinha, Bodh Capital

Answered

We supply landing gears, doors, spherical bearings to Sukhoi and defense aircraft. Customization is extreme; global competitors sold off aerospace plans due to inability to navigate. NRB thrives in customized aerospace solutions. We have a structural moat here.

Guidance

Forward guidance and management's confidence

FY31 ₹2,730 Cr extrapolated from 14.38% CAGR base

Medium

FY27 implied baseline ~₹1,500–1,600 Cr; requires sustained mid-teen CAGR. Unitec/MTR ramps support case. No formal FY28/29 milestones given.

Growth trajectory towards 20% (vs prior 15% aspirational)

Low

Informal restatement; delivered 18.8% YoY but analysts noted 15% prior guidance. No quantified FY27 full-year target provided.

EBITDA margin 18–20% reaffirmed (annualized)

High

Q2 delivered 18.2%, within range. Management said 'once we reach new growth threshold, sustain and surpass' (implying scalability). Not guaranteeing expansion from 18%, but maintaining range.

₹270 Cr total capex (from prior ₹120 Cr); Unitec JV ₹110 Cr portion

High

Unitec on track April 2027 commissioning. Remaining capex for organic capacity, R&D. Phased across FY27–FY28.

Risks the call surfaced

Ranked by how much they should concern a holder

Margin compression

High

PAT fell 12.5% YoY; NPM compressed from 10.6% to 9.3%. Cost inflation (19% other expense rise) outpacing price realization on new products. JV ramps will absorb capex and R&D, delaying profit inflection.

JV execution risk

Medium

Unitec JV (₹110 Cr capex, April 2027 commissioning, ₹130 Cr revenue potential) and Mahant Tool Room (₹55 lakh Q2 revenue, 9-month ramp to ₹1 Cr quarterly) are material to FY28+ growth thesis. Commissioning delays or lower-than-expected ramps would undermine guidance.

Customer concentration

Medium

Top 10 customers represent bulk of sales (management stated this explicitly). Loss of single OEM platform (e.g., BMW win delayed, Mahant Tool Room customer defection) could disrupt growth trajectory. No customer >10% of sales mentioned (healthy), but concentration in tier-one OEMs is real.

EV demand execution

Medium

EV adjacency (high-frequency drives, commercial EV, e-mobility) is a core 5-year narrative. However, absolute EV revenue today is immaterial; growth dependent on global OEM platform ramps (BMW from Jan 2027, Unitec JV unproven). EV segment growth could stall if OEM cycle delays.

Profit conversion risk

High

Core issue: PAT fell 12.5% YoY despite 18.8% revenue growth. This contradicts management's assertion of 'quality growth' and improved mix. Unless FY28 shows PAT re-acceleration, the long-term ₹2,730 Cr / 18–20% margin thesis will be questioned. Investors may repriced risk of further margin compression.

Management

Score 6/10. Candid on long-term strategy and competitive moat; evasive on near-term metrics. Refused to guide quarterly or semi-annual targets, citing 'conservative' philosophy. Transparent on JV mechanics and customer wins, but vague on cost inflation and margin expansion timeline. Delivered 18.8% revenue YoY (vs 15% prior aspiration, beat), but PAT fell 12.5% (profit execution miss). EBITDA margin 18.2% met range. Track record shows growth top-line, but profit leverage lagging. Capex tracking (Unitec April 2027 on track), but Mahant Tool Room still early-stage (₹55 lakh Q2 revenue).

What to watch next
  • 1 · Apr 2027

    Unitec JV commissioning; ramp to ₹130 Cr revenue potential

  • 2 · Jan 2027

    BMW platform win; new steering/powertrain bearings in all 2027+ models

  • 3 · H2 FY27

    Mahant Tool Room scaling to ₹1 Cr quarterly revenue run-rate (18-month pathway)

The core risk is whether organic profit growth can materialize while funding JVs and product development.

Informational and educational content only. Not investment advice.